南方医科大学学报 ›› 2026, Vol. 46 ›› Issue (7): 1543-1552.doi: 10.12122/j.issn.1673-4254.2026.07.08

• • 上一篇    

通窍活血汤含药脑脊液通过抑制血浆纤维蛋白原介导的 NLRP3炎性小体活化减轻氧糖剥夺/复糖复氧诱导的神经元损伤

王艳1(), 黄平1, 彭宇芹2, 孙浩2, 汪宁2,3,4(), 汪长中1()   

  1. 1.安徽中医药大学,中西医结合学院,安徽 合肥 230012
    2.安徽中医药大学,药学院,安徽 合肥 230012
    3.安徽中医药大学,中药研究与开发安徽省重点实验室,安徽 合肥 230012
    4.安徽中医药大学,中药复方安徽省重点实验室,安徽 合肥 230012
  • 收稿日期:2025-11-26 出版日期:2026-07-20 发布日期:2026-07-20
  • 通讯作者: 汪宁,汪长中 E-mail:yangwangsci@163.com;wnsci123@163.com;ahwcz63@sina.com
  • 作者简介:王 艳,博士,教授,硕士生导师,E-mail: yangwangsci@163.com
  • 基金资助:
    安徽省高校优秀科研创新团队项目(2022AH010034);安徽省高等学校科学研究重点项目(2023AH050738)

Tongqiao Huoxue Decoction-medicated rat cerebrospinal fluid attenuates oxygen and glucose deprivation-induced neuronal injury by suppressing fibrinogen-mediated NLRP3 inflammasome activation

Yan WANG1(), Ping HUANG1, Yuqin PENG2, hao SUN2, Ning WANG2,3,4(), Changzhong WANG1()   

  1. 1.School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei 230012, China
    2.School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China
    3.Anhui Provincial Key Laboratory of Research & Development of Chinese Medicine, Anhui University of Chinese Medicine, Hefei 230012, China
    4.Anhui Provincial Key Laboratory of Traditional Chinese Medicine Compounds, Anhui University of Chinese Medicine, Hefei 230012, China
  • Received:2025-11-26 Online:2026-07-20 Published:2026-07-20
  • Contact: Ning WANG, Changzhong WANG E-mail:yangwangsci@163.com;wnsci123@163.com;ahwcz63@sina.com

摘要:

目的 探讨通窍活血汤含药脑脊液(TQHXD-CSF)对氧糖剥夺/复糖复氧(OGD/R)损伤小鼠小胶质细胞(BV-2)炎症损伤的修复作用,以及其对共培养体系中神经元(HT22)细胞的保护作用。 方法 采用Transwell共培养体系,将BV-2细胞与HT22细胞进行共培养;对Transwell小室中BV-2细胞建立OGD/R+FIB损伤模型后,给予TQHXD-CSF干预,下层HT22细胞正常培养。通过倒置显微镜观察各组BV-2细胞形态变化;采用CCK-8法检测各组细胞存活率;流式细胞术分析细胞内活性氧(ROS)含量及细胞凋亡率;CD86/CD206免疫荧光双染法观察BV-2细胞极化表型;透射电镜结合流式细胞术鉴定并定量含纤维蛋白原(FIB)的细胞外囊泡(EVs);Western blotting法检测NLRP3炎性体相关蛋白(NLRP3、ASC、Caspase-1、GSDMD)及炎症因子(IL-1β、IL-18)的表达水平;Pull-down实验验证FIB与NLRP3蛋白的相互作用。 结果 OGD/R+FIB损伤可显著诱导BV-2细胞向M1型促炎表型极化,上调CD86表达水平,增加含FIB的EVs释放,激活NLRP3炎性体通路(P<0.01);进而导致共培养的HT22细胞活力下降、ROS生成增多、凋亡率升高(P<0.01)。TQHXD-CSF干预后,可显著促进BV-2细胞向M2型抗炎表型极化,上调抗炎标志物CD206表达,减少含FIB的EVs分泌(P<0.01);同时可显著抑制BV-2细胞活化介导的HT22细胞中NLRP3、ASC、Caspase-1、GSDMD、IL-1β、IL-18的蛋白表达,抑制NLRP3炎性体过度激活,明显改善HT22细胞的炎症损伤及凋亡情况(P<0.01)。Pull-down实验证实,FIB与NLRP3蛋白之间存在直接相互作用。 结论 TQHXD-CSF可通过抑制OGD/R+FIB损伤后BV-2细胞释放含FIB的EVs,阻断NLRP3炎性体激活介导的炎症反应,对HT22细胞发挥保护作用,为减轻缺血性脑卒中后的神经炎症损伤提供实验依据。

关键词: 通窍活血汤, 含药脑脊液, 纤维蛋白原, NLRP3炎症小体, 细胞外囊泡

Abstract:

Objective To examine the protective effects of cerebrospinal fluid from Tongqiao Huoxue Decoction-treated rats (TQHXD-CSF) against oxygen and glucose deprivation and reoxygenation (OGD/R)-induced injury in murine BV-2 microglial cells and co-cultured HT22 cells. Methods In a Transwell co-culture system of BV-2 and HT22 cells, OGD/R+fibrinogen (FIB) injury was induced in BV-2 cells followed by treatment with TQHXD-CSF intervention, and HT22 cells in the lower chamber were cultured under normal conditions. The cells were observed for changes in cell morphology, viability, intracellular ROS level, apoptosis, M1/M2 polarization, and FIB-containing extracellular vesicles (EVs). The cellular expressions of NLRP3, ASC, caspase-1, GSDMD, IL-1β, and IL-18 were quantified using Western blotting, and FIB-NLRP3 binding was confirmed by pull-down assay. Results OGD/R+FIB injury caused polarization of BV-2 cells to the pro-inflammatory M1 phenotype, increased CD86 expression and release of FIB-containing EVs, and activated the NLRP3 inflammasome. The co-cultured HT22 cells showed reduced cell viability, elevated ROS, and increased cells apoptosis. Treatment with TQHXD-CSF promoted M2 polarization in BV-2 cells, upregulated CD206 expression, suppressed FIB+ EVs secretion, and inhibited NLRP3 inflammasome activation in HT22 cells, which showed significantly lowered expressions of NLRP3, ASC, caspase-1, GSDMD, IL-1β, and IL-18 proteins and hence reduced inflammatory injury and cell apoptosis. Pull-down assay confirmed direct FIB and NLRP3 binding. Conclusion In the co-culture system of BV-2 cells and HT22 cells, TQHXD-CSF treatment protects HT22 cells against OGD/R+FIB-induced injury by inhibiting FIB-containing EVs release from BV-2 cells and suppressing NLRP3 inflammasome activation.

Key words: Tongqiao Huoxue Decoction, medicated cerebrospinal fluid, fibrinogen, NLRP3 inflammasome, extracellular vesicles